Skip to content

A Comprehensive Intervention Strategy and Application for Managing Symptom Experience in Patients with Hepatic Alveolar Echinococcosis Following Autologous Liver Transplantation Based on SMT

A Comprehensive Intervention Strategy and Application for Managing Symptom Experience in Patients with Hepatic Alveolar Echinococcosis Following Autologous Liver Transplantation Based on SMT

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500107533
Enrollment
Unknown
Registered
2025-08-13
Start date
2024-02-11
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatic echinococcosis

Interventions

Control group:Health education, medication care, tube care, jaundice care, psychological care, etc. were carried out in accordance with the postoperative care routine of ELRA.
Test group:A comprehensive intervention strategy for symptom management is applied on the basis of routine care

Sponsors

The First Affiliated Hospital of Xinjiang Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. It complies with the diagnostic criteria for echinococcosis and the surgical indications for liver transplantation as stipulated in the "Expert Consensus on the Diagnosis and Treatment of Two Types of Hepatic Echinococcosis (2019 Edition)"; 2. Patients after autologous liver transplantation for hepatic alveolar echinococcosis; 3.18 to 65 years old; 4. Be able to communicate well with researchers and complete questionnaires and evaluations in accordance with research requirements. 5. Informed consent and voluntary participation in this survey.

Exclusion criteria

Exclusion criteria: 1. Those with unstable emotions and conditions; 2. Those with other serious diseases; 3. Those who died during the study period.

Design outcomes

Primary

MeasureTime frame
Degree of postoperative fatigue;Sleep quality;Pain effect;Quality of life;Anxiety and depression;

Countries

China

Contacts

Public ContactZhao Ping

Department of Hepatobiliary Surgery, the First Affiliated Hospital of Xinjiang Medical University

zhaoping4363774@163.com+86 136 0996 1615

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026